Oncology
Muhamed Baljevic, M.D.
Associate Professor of Medicine, Director, Multiple Myeloma Program, Vanderbilt-Ingram Cancer Center
Muhamed Baljevic, MD, FACP, is an Associate Professor of Medicine in the Division of Hematology/Oncology at Vanderbilt University Medical Center in Nashville, Tennessee, where he serves as Director of the Multiple Myeloma Program, Plasma Cell Disorders Research Program, and Vanderbilt Amyloidosis Multidisciplinary (VAMP) Program. He also acts as Disease Team Lead for plasma cell dyscrasias and lymphomas at the Vanderbilt-Ingram Cancer Center. Dr. Baljevic specializes in treating multiple myeloma
16+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
- Hematology (American Board of Internal Medicine)
- Internal Medicine (implied via training, ABIM via fellowships)
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer Center — Fellowship, Hematology and Medical Oncology, 2013-2016
- New York Presbyterian Hospital (Cornell Campus)/Weill Cornell Medical Center — Residency, Internal Medicine, 2010-2013
- Weill Cornell Medical College in Qatar — M.D., Class of 2010
- Weill Cornell Medical Center/Cornell University Medical Center — Internship, Internal Medicine, 2011
Peer Recognition
- ASCO/AACR — Workshop on Methods in Clinical Cancer Research
2015
- Celgene — Future Leaders in Hematology Award for Clinical Research
2014
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Vanderbilt University Medical Center
- Vanderbilt Wilson County Hospital
Languages
Bosnian, English
Experience
16+ years in practice